Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 687-693

  Lee, Fa Yauh ^a   Suh Sang, Wang ^a   Yang Te, Tsai ^a   Hwai Jeng, Lin ^a   Han Chieh, Lin ^a   Chi Jen, Chu ^a   Shwu Ling, Wu ^a   Chung Ching, Tai ^a   Shou Dong, Lee ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

aminoguanidine; hyperdynamic circulation; nitric oxide; portal hypertension; portal hypertensive gastropathy

Indexed keywords

AMINOGUANIDINE; PLACEBO;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; HEART INDEX; HEART OUTPUT; HEMODYNAMICS; MALE; MORPHOMETRICS; NONHUMAN; ORGAN BLOOD FLOW; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; STOMACH DISEASE; STOMACH MUCOSA; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0343683298     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80436-9     Document Type: Article

References (35)

1. D'Amico G, Montalbano L, Traina M, Pisa R, Menozzi M, Spanò C, Pagliaro L. Cerrello Hospital. Natural history of congestive gastropathy in cirrhosis. Gastroenterology. 99:1990;1558-1564.
2. McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, Triger DR. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut. 26:1985;1226-1232.
3. Quintero E, Piqué JM, Bombí JA, Bordas JM, Sentis J, Elena M, Bosh J, Rodés J. Gastric mucosal vascular ectasia causing bleeding in cirrhosis: a distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology. 93:1987;1054-1061.
4. Albillos A, Colombato LA, Enriquez R, Cheng O, Sikuler E, Groszmann RJ. Sequence of morphological and hemodynamic changes of gastric microvessels in portal hypertension. Gastroenterology. 102:1992;2066-2070.
5. Kitano S, Koyanagi N, Sugimuchi K, Kobayashi M, Inokuchi K. Mucosal blood flow and modified vascular responses to norepinephrine in the stomach of rats with liver cirrhosis. Eur Surg Res. 14:1982;221-230.
6. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol. 244:1983;G52-G57.
7. Benoit JN, Granger DN. Splanchnic hemodynamics in chronic portal venous hypertension. Semin Liver Dis. 6:1986;287-298.
8. Piqué JM, Leung FW, Kitahora T, Farfeh IJ, Tarnawski A, Guth PH. Gastric mucosal blood flow and acid secretion in portal hypertensive rats. Gastroenterology. 95:1988;727-733.
9. Geraghty JG, Angerson WJ, Carter DC. Autoradiographic study of the regional distribution of gastric blood flow in portal hypertensive rats. Gastroenterology. 97:1989;1108-1114.
10. Groszmann RJ, Colombato LA. Gastric vascular changes in portal hypertension. Hepatology. 8:1988;1708-1710.
11. Pizcueta P, Piqué JM, Fernández M, Bosch J, Rodés J, Whittle BJR, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology. 103:1992;1909-19155.
12. Casadevall M, Panés J, Piqué JM, Marroni N, Bosch J, Whittle BJR. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology. 18:1993;628-634.
13. Vallance P, Moncada S. Hypothesis: induction of nitric oxide synthase in the vasculature underlies the hyperdynamic circulation of cirrhosis. Lancet. 337:1991;776-778.
14. Griffiths MJD, Messent M, MacAllister RJ, Evans TW. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol. 110:1993;963-968.
15. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 233:1993;119-125.
16. Lopez-Talavera JC, Groszmann RJ. treatment with aminoguanidine, a specific inhibitor of the induible nitric oxide synthase, ameliorates the hyperdynamic syndrome in portal hypertensive rats. Hepatology. 20:1994;143A. (abstract).
17. Chojkier M, Goroszmann RJ. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol. 240:1981;G371-G375.
18. Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology. 102:1992;931-935.
19. Panés J, Casadevall M, Fernández M, Piqué JM, Bosch J, Casamitjana R, Cirera I, Bombí JA, Terés J, Rodés J. Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment. Hepatology. 20:1994;1261-1270.
20. AutoCad Release 12 Reference Manual. 1992;Autodesk Inc.
21. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 248:1985;G618-G625.
22. Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology. 16:1992;1043-1048.
23. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in mesenteric vessel of portal hypertensive rats: reversal by blockade of nitric oxide formation. Am J Physiol. 462:1992;G996-G1001.
24. Pizcueta MP, Piqué JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting niric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol. 105:1992;184-190.
25. ω-Nitro-L-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology. 17:1993;84-90.
26. Sogni P, Morean R, Ohsuga M, Cailmail S, Oberti F, Hadengue A, Pussard E, Lebrec D. Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis. Hepatology. 16:1992;980-983.
27. Iwata F, Joh T, Kawai T, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol. 263:1992;G149-G154.
28. Wu Y, Burns RC, Stizmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology. 18:1993;1416-1421.
29. ω-Nitro-L arginine ameliorates portal-systemic shunting in portal hypertensive rats. Gastroenterology. 105:1993;1464-1470.
30. Laszlo F, Evans SM, Whittle BJR. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal micrivasculature in vivo. Eur J Pharmacol. 272:1995;169-175.
31. Fernández M, García-Pagán JC, Casadevall M, Bernadich C, Piera C, Whittle BJR, Piqué JM, Bosch J, Rodés J. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology. 108:1995;1487-1495.
32. Morales M, Jiménez W, Ros J, Leivas A, Pérez-Sala D, Lamas S, Arroyo V, Rivera F, Rodés J. Transcriptional activation of inducible nitric oxide synthase in arterial vessels of cirrhotic rats. Hepatology. 22:1995;155A. (Abstract).
33. Martin PY, Xu DL, Niederberger M, Weigert A, Tsai P, St John J, Gines P, Schrier RW. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol. 270:1996;494-499.
34. Tanoue K, Ohta M, Tarnawski AS, Wahlstrom KJ, Sugimachi K, Sarfeh IJ. Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology. 110:1996;549-557.
35. Soubrane O, Lacronique V, Miquerol L, Mignon A, Houssin D. The role of inducible NO synthase (iNOS) in the hyperdynamic circulation of portal hypertension. Hepatology. 22:1995;156A. (abstract).